Acute Triage Clinician
suPARnostic® can be an aid for risk stratification in the Acute Care SettingRead more
Jesper Eugen-Olsen is founder and member of the board since 2001. His research and invention led to the establishment of ViroGates
Jesper Eugen-Olsen is Chief Scientific Officer of ViroGates and Laboratory Research Director of the Clinical Research Centre, Copenhagen University Hospital, Hvidovre, Denmark (1998-present ). Prior to his current position at Hvidovre Hospital, he served as Research Associate at the Department of Infectious Medicine (1995) and as Principal Investigator at the Laboratory of Molecular Immunology, Hvidovre Hospital (1997).
He is a member of various scientific committees on e.g. XII and XIII International AIDS Conferences in Geneva and South Africa and the author and co-author of more than 50 scientific peer reviewed publications and holds 11 patents.
He holds a M.Sc. in Biochemistry from the Institute of Medical Biochemistry and Genetics, University of Copenhagen (1994) and a PhD in HIV prognostics from the University of Copenhagen (2003).
Knut Borch-Johnsen supports the Executive Team in scientific matters and assumed this role in 2007.
Dr. Borch-Johnsen is the Medical Director for the renowned Steno Diabetes Center. He started his career as a Research Fellow at the Steno Diabetes Center in Denmark (1982). His career includes clinical positions in Hillerød County Hospital (1987-89), State University Hospital (1989-91) and Glostrup University Hospital (1993-97). He has also been Chief Physician in Steno Diabetes Center 1997-2000, Head of the Copenhagen Country Centre of Preventive Medicine 1993-1997 and Senior Research Fellow in the Institute of Preventive Medicine 1992-93.
Knut Borch-Johnson holds an MD (1981) as well as a DMSc (1989), both from the University of Copenhagen. He is also a Specialist in internal medicine (1994) and has been an Adjunct Professor of Clinical Epidemiology at the Aarhus University, Denmark (2001).
Peter Aaby supports the Executive Team in scientific matters and assumed this role in 2002.
Peter Aaby is a Professor at Epidemiological Research Unit, Statens Serum Institute, Denmark and Head of the Bandim Health Project in Guinea Bissau. Since 1993, he has been a Senior Researcher and Project Manager of community studies of infectious diseases and primary healthcare in Guinea Bissau.
He started his career as a researcher at the Institute of Ethnology and Anthropology, University of Copenhagen (1976-78) and has since then held several positions including Lecturer, Institute of Ethnology, Uppsala, Sweden (1978-80), Senior Lecturer, Institute of Ethnology and Anthropology, University of Copenhagen (1981-91) and Adjunct professor of International Health, University of Copenhagen (1998). In addition, he has served as Principal investigator on IRD's study of long-term efficacy and safety of high-titer measles vaccine in Niakhar, Senegal (affiliated IRD) (1990- ).
Peter Aaby has been a member of the ad-hoc Committee on AIDS under IUSSP (1991-93) and received the Novo Nordic Award in 2000. His is author or co-author of 170 scientific papers, letters and reviews, 31 proceedings/book chapters and 7 double publications in Epidemiology of Infectious Diseases (measles, measles immunization, diarrhoea, HIV-2).
He holds a M.Sc. in Social Anthropology from the University of Copenhagen (1974) and a Dr.Med.Sci. from the University of Copenhagen (1988).
Jan Kyhse-Andersen supports the Executive Team in scientific and operational matters and assumed his role in 2005. He is providing services with assay development, -validation, production as well as QC and QA issues.
Jan holds a position as senior manager in Business Development at Novozymes A/S.
He has his own advisory service company, Kyhse-Andersen, since 2004, and he holds a position as supervisory Board Member in Life Equity Sweden KB, a privately equity fund since 2005.
Prior to joining Novozymes, Jan was Vice President, R&D and Production at Vir A/S (2004). He started his career as post doc at Technology University of Denmark (1987). Jan then joined DAKO A/S where he had several managerial positions: Diagnostic assay development (1989), Sales and Marketing (1993), R&D manager (1994) and subsequently Director of Immuno-production (1998-2001). Jan joined Vir A/S as Chief Scientific Officer (CSO) in 2001.
Jan was founder and CEO of JKA-biotech ApS (1983-88) and founder and board member of Kem-En-Tec A/S (1988-91).
He holds a M.Sc. in chemical engineering (1983) and a Ph.D. (1987) from Technology University of Denmark.